Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 180 entries
Sorted by: Best Match Show Resources per page
Aged Gut Microbiota Contributes to Systemical Inflammaging after Transfer to Germ-Free Mice.

Frontiers in immunology

Fransen F, van Beek AA, Borghuis T, Aidy SE, Hugenholtz F, van der Gaast-de Jongh C, Savelkoul HFJ, De Jonge MI, Boekschoten MV, Smidt H, Faas MM, de Vos P.
PMID: 29163474
Front Immunol. 2017 Nov 02;8:1385. doi: 10.3389/fimmu.2017.01385. eCollection 2017.

Advanced age is associated with chronic low-grade inflammation, which is usually referred to as inflammaging. Elderly are also known to have an altered gut microbiota composition. However, whether inflammaging is a cause or consequence of an altered gut microbiota...

Cite
Fransen F, van Beek AA, Borghuis T, et al. Aged Gut Microbiota Contributes to Systemical Inflammaging after Transfer to Germ-Free Mice. Front Immunol. 2017;8:1385doi: 10.3389/fimmu.2017.01385.
Fransen, F., van Beek, A. A., Borghuis, T., Aidy, S. E., Hugenholtz, F., van der Gaast-de Jongh, C., Savelkoul, H. F. J., De Jonge, M. I., Boekschoten, M. V., Smidt, H., Faas, M. M., & de Vos, P. (2017). Aged Gut Microbiota Contributes to Systemical Inflammaging after Transfer to Germ-Free Mice. Frontiers in immunology, 81385. https://doi.org/10.3389/fimmu.2017.01385
Fransen, Floris, et al. "Aged Gut Microbiota Contributes to Systemical Inflammaging after Transfer to Germ-Free Mice." Frontiers in immunology vol. 8 (2017): 1385. doi: https://doi.org/10.3389/fimmu.2017.01385
Fransen F, van Beek AA, Borghuis T, Aidy SE, Hugenholtz F, van der Gaast-de Jongh C, Savelkoul HFJ, De Jonge MI, Boekschoten MV, Smidt H, Faas MM, de Vos P. Aged Gut Microbiota Contributes to Systemical Inflammaging after Transfer to Germ-Free Mice. Front Immunol. 2017 Nov 02;8:1385. doi: 10.3389/fimmu.2017.01385. eCollection 2017. PMID: 29163474; PMCID: PMC5674680.
Copy Download .nbib Format: NLM
The Impact of Gut Microbiota on Gender-Specific Differences in Immunity.

Frontiers in immunology

Fransen F, van Beek AA, Borghuis T, Meijer B, Hugenholtz F, van der Gaast-de Jongh C, Savelkoul HF, de Jonge MI, Faas MM, Boekschoten MV, Smidt H, El Aidy S, de Vos P.
PMID: 28713378
Front Immunol. 2017 Jun 30;8:754. doi: 10.3389/fimmu.2017.00754. eCollection 2017.

Males and females are known to have gender-specific differences in their immune system and gut microbiota composition. Whether these differences in gut microbiota composition are a cause or consequence of differences in the immune system is not known. To...

Cite
Fransen F, van Beek AA, Borghuis T, et al. The Impact of Gut Microbiota on Gender-Specific Differences in Immunity. Front Immunol. 2017;8:754doi: 10.3389/fimmu.2017.00754.
Fransen, F., van Beek, A. A., Borghuis, T., Meijer, B., Hugenholtz, F., van der Gaast-de Jongh, C., Savelkoul, H. F., de Jonge, M. I., Faas, M. M., Boekschoten, M. V., Smidt, H., El Aidy, S., & de Vos, P. (2017). The Impact of Gut Microbiota on Gender-Specific Differences in Immunity. Frontiers in immunology, 8754. https://doi.org/10.3389/fimmu.2017.00754
Fransen, Floris, et al. "The Impact of Gut Microbiota on Gender-Specific Differences in Immunity." Frontiers in immunology vol. 8 (2017): 754. doi: https://doi.org/10.3389/fimmu.2017.00754
Fransen F, van Beek AA, Borghuis T, Meijer B, Hugenholtz F, van der Gaast-de Jongh C, Savelkoul HF, de Jonge MI, Faas MM, Boekschoten MV, Smidt H, El Aidy S, de Vos P. The Impact of Gut Microbiota on Gender-Specific Differences in Immunity. Front Immunol. 2017 Jun 30;8:754. doi: 10.3389/fimmu.2017.00754. eCollection 2017. PMID: 28713378; PMCID: PMC5491612.
Copy Download .nbib Format: NLM
A Rare Case of Bilateral Proptosis.

European journal of case reports in internal medicine

Serodio JF, Jonet M, Trinidade M, Coutinho I, Favas C.
PMID: 30755988
Eur J Case Rep Intern Med. 2018 Nov 28;5(11):000966. doi: 10.12890/2018_000966. eCollection 2018.

A 65-year-old man presented with a 2-year history of severe bilateral proptosis, palpable lymphadenopathy and moderate hepatosplenomegaly. A blood test was positive for hepatitis C infection. CT showed palpebral infiltrative lesions with regional progression through the temporal and masticatory...

Cite
Serodio JF, Jonet M, Trinidade M, et al. A Rare Case of Bilateral Proptosis. Eur J Case Rep Intern Med. 2018;5(11):000966doi: 10.12890/2018_000966.
Serodio, J. F., Jonet, M., Trinidade, M., Coutinho, I., & Favas, C. (2018). A Rare Case of Bilateral Proptosis. European journal of case reports in internal medicine, 5(11), 000966. https://doi.org/10.12890/2018_000966
Serodio, Joao Fernandes, et al. "A Rare Case of Bilateral Proptosis." European journal of case reports in internal medicine vol. 5,11 (2018): 000966. doi: https://doi.org/10.12890/2018_000966
Serodio JF, Jonet M, Trinidade M, Coutinho I, Favas C. A Rare Case of Bilateral Proptosis. Eur J Case Rep Intern Med. 2018 Nov 28;5(11):000966. doi: 10.12890/2018_000966. eCollection 2018. PMID: 30755988; PMCID: PMC6346810.
Copy Download .nbib Format: NLM
Antidepressant use during pregnancy and development of preeclampsia: A focus on classes of action and specific transporters/receptors targeted by antidepressants.

Journal of psychiatric research

Tran YH, Huynh HK, Faas MM, de Vos S, Groen H.
PMID: 34959164
J Psychiatr Res. 2021 Dec 22;146:92-101. doi: 10.1016/j.jpsychires.2021.12.038. Epub 2021 Dec 22.

OBJECTIVE: The association between antidepressants and preeclampsia has been inconsistently reported. Given the compound-specific variable affinity for different transporters/receptors, their effect on preeclampsia risk could differ. Our study examined the risk of preeclampsia (and its subtypes) following exposure to...

Cite
Tran YH, Huynh HK, Faas MM, et al. Antidepressant use during pregnancy and development of preeclampsia: A focus on classes of action and specific transporters/receptors targeted by antidepressants. J Psychiatr Res. 2021;146:92-101doi: 10.1016/j.jpsychires.2021.12.038.
Tran, Y. H., Huynh, H. K., Faas, M. M., de Vos, S., & Groen, H. (2021). Antidepressant use during pregnancy and development of preeclampsia: A focus on classes of action and specific transporters/receptors targeted by antidepressants. Journal of psychiatric research, 14692-101. https://doi.org/10.1016/j.jpsychires.2021.12.038
Tran, Yen-Hao, et al. "Antidepressant use during pregnancy and development of preeclampsia: A focus on classes of action and specific transporters/receptors targeted by antidepressants." Journal of psychiatric research vol. 146 (2021): 92-101. doi: https://doi.org/10.1016/j.jpsychires.2021.12.038
Tran YH, Huynh HK, Faas MM, de Vos S, Groen H. Antidepressant use during pregnancy and development of preeclampsia: A focus on classes of action and specific transporters/receptors targeted by antidepressants. J Psychiatr Res. 2021 Dec 22;146:92-101. doi: 10.1016/j.jpsychires.2021.12.038. Epub 2021 Dec 22. PMID: 34959164.
Copy Download .nbib Format: NLM
Antidepressant use during pregnancy and development of preeclampsia: A focus on classes of action and specific transporters/receptors targeted by antidepressants.

Journal of psychiatric research

Tran YH, Huynh HK, Faas MM, de Vos S, Groen H.
PMID: 34959164
J Psychiatr Res. 2021 Dec 22;146:92-101. doi: 10.1016/j.jpsychires.2021.12.038. Epub 2021 Dec 22.

OBJECTIVE: The association between antidepressants and preeclampsia has been inconsistently reported. Given the compound-specific variable affinity for different transporters/receptors, their effect on preeclampsia risk could differ. Our study examined the risk of preeclampsia (and its subtypes) following exposure to...

Cite
Tran YH, Huynh HK, Faas MM, et al. Antidepressant use during pregnancy and development of preeclampsia: A focus on classes of action and specific transporters/receptors targeted by antidepressants. J Psychiatr Res. 2021;146:92-101doi: 10.1016/j.jpsychires.2021.12.038.
Tran, Y. H., Huynh, H. K., Faas, M. M., de Vos, S., & Groen, H. (2021). Antidepressant use during pregnancy and development of preeclampsia: A focus on classes of action and specific transporters/receptors targeted by antidepressants. Journal of psychiatric research, 14692-101. https://doi.org/10.1016/j.jpsychires.2021.12.038
Tran, Yen-Hao, et al. "Antidepressant use during pregnancy and development of preeclampsia: A focus on classes of action and specific transporters/receptors targeted by antidepressants." Journal of psychiatric research vol. 146 (2021): 92-101. doi: https://doi.org/10.1016/j.jpsychires.2021.12.038
Tran YH, Huynh HK, Faas MM, de Vos S, Groen H. Antidepressant use during pregnancy and development of preeclampsia: A focus on classes of action and specific transporters/receptors targeted by antidepressants. J Psychiatr Res. 2021 Dec 22;146:92-101. doi: 10.1016/j.jpsychires.2021.12.038. Epub 2021 Dec 22. PMID: 34959164.
Copy Download .nbib Format: NLM
Development of a new COVID-19 panel survey: the IAB high-frequency online personal panel (HOPP).

Journal for labour market research

Haas GC, Müller B, Osiander C, Schmidtke J, Trahms A, Volkert M, Zins S.
PMID: 34179683
J Labour Mark Res. 2021;55(1):16. doi: 10.1186/s12651-021-00295-z. Epub 2021 Jun 23.

Since January 2020, the COVID-19 crisis has affected everyday life around the world, and rigorous government lockdown restrictions have been implemented to prevent the further spread of the pandemic. The consequences of the corona crisis and the associated lockdown...

Cite
Haas GC, Müller B, Osiander C, et al. Development of a new COVID-19 panel survey: the IAB high-frequency online personal panel (HOPP). J Labour Mark Res. 2021;55(1):16doi: 10.1186/s12651-021-00295-z.
Haas, G. C., Müller, B., Osiander, C., Schmidtke, J., Trahms, A., Volkert, M., & Zins, S. (2021). Development of a new COVID-19 panel survey: the IAB high-frequency online personal panel (HOPP). Journal for labour market research, 55(1), 16. https://doi.org/10.1186/s12651-021-00295-z
Haas, Georg-Christoph, et al. "Development of a new COVID-19 panel survey: the IAB high-frequency online personal panel (HOPP)." Journal for labour market research vol. 55,1 (2021): 16. doi: https://doi.org/10.1186/s12651-021-00295-z
Haas GC, Müller B, Osiander C, Schmidtke J, Trahms A, Volkert M, Zins S. Development of a new COVID-19 panel survey: the IAB high-frequency online personal panel (HOPP). J Labour Mark Res. 2021;55(1):16. doi: 10.1186/s12651-021-00295-z. Epub 2021 Jun 23. PMID: 34179683; PMCID: PMC8220878.
Copy Download .nbib Format: NLM
Effects of left ventricular assist device on pulmonary functions and pulmonary hemodynamics: A meta-analysis. [email protected].

World journal of cardiology

Ullah W, Meizinger C, Ali Z, Panchal A, Saeed R, Haas DC, Rame E.
PMID: 33312440
World J Cardiol. 2020 Nov 26;12(11):550-558. doi: 10.4330/wjc.v12.i11.550.

BACKGROUND: Given current evidence, the effect of left ventricular assist device (LVAD) implantation on pulmonary function tests remains controversial.AIM: To better understand the factors contributing to the changes seen on pulmonary function testing and the correlation with pulmonary hemodynamics...

Cite
Ullah W, Meizinger C, Ali Z, et al. Effects of left ventricular assist device on pulmonary functions and pulmonary hemodynamics: A meta-analysis. [email protected]. World J Cardiol. 2020;12(11):550-558doi: 10.4330/wjc.v12.i11.550.
Ullah, W., Meizinger, C., Ali, Z., Panchal, A., Saeed, R., Haas, D. C., & Rame, E. (2020). Effects of left ventricular assist device on pulmonary functions and pulmonary hemodynamics: A meta-analysis. [email protected]. World journal of cardiology, 12(11), 550-558. https://doi.org/10.4330/wjc.v12.i11.550
Ullah, Waqas, et al. "Effects of left ventricular assist device on pulmonary functions and pulmonary hemodynamics: A meta-analysis. [email protected]." World journal of cardiology vol. 12,11 (2020): 550-558. doi: https://doi.org/10.4330/wjc.v12.i11.550
Ullah W, Meizinger C, Ali Z, Panchal A, Saeed R, Haas DC, Rame E. Effects of left ventricular assist device on pulmonary functions and pulmonary hemodynamics: A meta-analysis. [email protected]. World J Cardiol. 2020 Nov 26;12(11):550-558. doi: 10.4330/wjc.v12.i11.550. PMID: 33312440; PMCID: PMC7701900.
Copy Download .nbib Format: NLM
Predictability of CRP and D-Dimer levels for in-hospital outcomes and mortality of COVID-19.

Journal of community hospital internal medicine perspectives

Ullah W, Thalambedu N, Haq S, Saeed R, Khanal S, Tariq S, Roomi S, Madara J, Boigon M, Haas DC, Fischman DL.
PMID: 33235672
J Community Hosp Intern Med Perspect. 2020 Sep 03;10(5):402-408. doi: 10.1080/20009666.2020.1798141.

BACKGROUND: Systemic inflammation elicited by a cytokine storm is considered a hallmark of coronavirus disease 2019 (COVID-19). This study aims to assess the clinical utility of the C-reactive protein (CRP) and D-Dimer levels for predicting in-hospital outcomes in COVID-19.METHODS:...

Cite
Ullah W, Thalambedu N, Haq S, et al. Predictability of CRP and D-Dimer levels for in-hospital outcomes and mortality of COVID-19. J Community Hosp Intern Med Perspect. 2020;10(5):402-408doi: 10.1080/20009666.2020.1798141.
Ullah, W., Thalambedu, N., Haq, S., Saeed, R., Khanal, S., Tariq, S., Roomi, S., Madara, J., Boigon, M., Haas, D. C., & Fischman, D. L. (2020). Predictability of CRP and D-Dimer levels for in-hospital outcomes and mortality of COVID-19. Journal of community hospital internal medicine perspectives, 10(5), 402-408. https://doi.org/10.1080/20009666.2020.1798141
Ullah, Waqas, et al. "Predictability of CRP and D-Dimer levels for in-hospital outcomes and mortality of COVID-19." Journal of community hospital internal medicine perspectives vol. 10,5 (2020): 402-408. doi: https://doi.org/10.1080/20009666.2020.1798141
Ullah W, Thalambedu N, Haq S, Saeed R, Khanal S, Tariq S, Roomi S, Madara J, Boigon M, Haas DC, Fischman DL. Predictability of CRP and D-Dimer levels for in-hospital outcomes and mortality of COVID-19. J Community Hosp Intern Med Perspect. 2020 Sep 03;10(5):402-408. doi: 10.1080/20009666.2020.1798141. PMID: 33235672; PMCID: PMC7671719.
Copy Download .nbib Format: NLM
Response to letter to the editor.

Pregnancy hypertension

Schuitemaker JHN, Beernink RHJ, Cremers TIFH, Scherjon SA, Van Pampus MG, Faas MM.
PMID: 34800777
Pregnancy Hypertens. 2021 Nov 05;27:6-7. doi: 10.1016/j.preghy.2021.10.011. Epub 2021 Nov 05.

No abstract available.

Cite
Schuitemaker JHN, Beernink RHJ, Cremers TIFH, et al. Response to letter to the editor. Pregnancy Hypertens. 2021;27:6-7doi: 10.1016/j.preghy.2021.10.011.
Schuitemaker, J. H. N., Beernink, R. H. J., Cremers, T. I. F. H., Scherjon, S. A., Van Pampus, M. G., & Faas, M. M. (2021). Response to letter to the editor. Pregnancy hypertension, 276-7. https://doi.org/10.1016/j.preghy.2021.10.011
Schuitemaker, Joost H N, et al. "Response to letter to the editor." Pregnancy hypertension vol. 27 (2021): 6-7. doi: https://doi.org/10.1016/j.preghy.2021.10.011
Schuitemaker JHN, Beernink RHJ, Cremers TIFH, Scherjon SA, Van Pampus MG, Faas MM. Response to letter to the editor. Pregnancy Hypertens. 2021 Nov 05;27:6-7. doi: 10.1016/j.preghy.2021.10.011. Epub 2021 Nov 05. PMID: 34800777.
Copy Download .nbib Format: NLM
Considerations for planning COVID-19 treatment services in humanitarian responses.

Conflict and health

Garry S, Abdelmagid N, Baxter L, Roberts N, le Polain de Waroux O, Ismail S, Ratnayake R, Favas C, Lewis E, Checchi F.
PMID: 33250932
Confl Health. 2020 Nov 25;14:80. doi: 10.1186/s13031-020-00325-6. eCollection 2020.

The COVID-19 pandemic has the potential to cause high morbidity and mortality in crisis-affected populations. Delivering COVID-19 treatment services in crisis settings will likely entail complex trade-offs between offering services of clinical benefit and minimising risks of nosocomial infection,...

Cite
Garry S, Abdelmagid N, Baxter L, et al. Considerations for planning COVID-19 treatment services in humanitarian responses. Confl Health. 2020;14:80doi: 10.1186/s13031-020-00325-6.
Garry, S., Abdelmagid, N., Baxter, L., Roberts, N., le Polain de Waroux, O., Ismail, S., Ratnayake, R., Favas, C., Lewis, E., & Checchi, F. (2020). Considerations for planning COVID-19 treatment services in humanitarian responses. Conflict and health, 1480. https://doi.org/10.1186/s13031-020-00325-6
Garry, Sylvia, et al. "Considerations for planning COVID-19 treatment services in humanitarian responses." Conflict and health vol. 14 (2020): 80. doi: https://doi.org/10.1186/s13031-020-00325-6
Garry S, Abdelmagid N, Baxter L, Roberts N, le Polain de Waroux O, Ismail S, Ratnayake R, Favas C, Lewis E, Checchi F. Considerations for planning COVID-19 treatment services in humanitarian responses. Confl Health. 2020 Nov 25;14:80. doi: 10.1186/s13031-020-00325-6. eCollection 2020. PMID: 33250932; PMCID: PMC7686825.
Copy Download .nbib Format: NLM
As the COVID-19 pandemic drags on, where have all the STEMIs gone?.

International journal of cardiology. Heart & vasculature

Ullah W, Sattar Y, Saeed R, Ahmad A, Boigon MI, Haas DC, Alraies MC.
PMID: 32550258
Int J Cardiol Heart Vasc. 2020 May 31;29:100550. doi: 10.1016/j.ijcha.2020.100550. eCollection 2020 Aug.

No abstract available.

Cite
Ullah W, Sattar Y, Saeed R, et al. As the COVID-19 pandemic drags on, where have all the STEMIs gone?. Int J Cardiol Heart Vasc. 2020;29:100550doi: 10.1016/j.ijcha.2020.100550.
Ullah, W., Sattar, Y., Saeed, R., Ahmad, A., Boigon, M. I., Haas, D. C., & Alraies, M. C. (2020). As the COVID-19 pandemic drags on, where have all the STEMIs gone?. International journal of cardiology. Heart & vasculature, 29100550. https://doi.org/10.1016/j.ijcha.2020.100550
Ullah, Waqas, et al. "As the COVID-19 pandemic drags on, where have all the STEMIs gone?." International journal of cardiology. Heart & vasculature vol. 29 (2020): 100550. doi: https://doi.org/10.1016/j.ijcha.2020.100550
Ullah W, Sattar Y, Saeed R, Ahmad A, Boigon MI, Haas DC, Alraies MC. As the COVID-19 pandemic drags on, where have all the STEMIs gone?. Int J Cardiol Heart Vasc. 2020 May 31;29:100550. doi: 10.1016/j.ijcha.2020.100550. eCollection 2020 Aug. PMID: 32550258; PMCID: PMC7261452.
Copy Download .nbib Format: NLM
A randomized crossover study comparing different tacrolimus formulations to reduce intrapatient variability in tacrolimus exposure in kidney transplant recipients.

Clinical and translational science

Bunthof KLW, Al-Hassany L, Nakshbandi G, Hesselink DA, van Schaik RHN, Ten Dam MAGJ, Baas MC, Hilbrands LB, van Gelder T.
PMID: 34905302
Clin Transl Sci. 2021 Dec 14; doi: 10.1111/cts.13206. Epub 2021 Dec 14.

A high intrapatient variability (IPV) in tacrolimus exposure is a risk factor for poor long-term outcomes after kidney transplantation. The main objective of this trial was to investigate whether tacrolimus IPV decreases after switching patients from immediate-release (IR)-tacrolimus to...

Cite
Bunthof KLW, Al-Hassany L, Nakshbandi G, et al. A randomized crossover study comparing different tacrolimus formulations to reduce intrapatient variability in tacrolimus exposure in kidney transplant recipients. Clin Transl Sci. 2021;doi: 10.1111/cts.13206.
Bunthof, K. L. W., Al-Hassany, L., Nakshbandi, G., Hesselink, D. A., van Schaik, R. H. N., Ten Dam, M. A. G. J., Baas, M. C., Hilbrands, L. B., & van Gelder, T. (2021). A randomized crossover study comparing different tacrolimus formulations to reduce intrapatient variability in tacrolimus exposure in kidney transplant recipients. Clinical and translational science, . https://doi.org/10.1111/cts.13206
Bunthof, Kim L W, et al. "A randomized crossover study comparing different tacrolimus formulations to reduce intrapatient variability in tacrolimus exposure in kidney transplant recipients." Clinical and translational science vol. (2021). doi: https://doi.org/10.1111/cts.13206
Bunthof KLW, Al-Hassany L, Nakshbandi G, Hesselink DA, van Schaik RHN, Ten Dam MAGJ, Baas MC, Hilbrands LB, van Gelder T. A randomized crossover study comparing different tacrolimus formulations to reduce intrapatient variability in tacrolimus exposure in kidney transplant recipients. Clin Transl Sci. 2021 Dec 14; doi: 10.1111/cts.13206. Epub 2021 Dec 14. PMID: 34905302.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 180 entries